Graham Cooper joined our Board of Directors in April 2017. From 2013 until 2015, Mr. Cooper was Chief Financial Officer of Receptos, Inc. until its sale to Celgene. Previously, in 2012 Mr. Cooper served as Chief Financial Officer of Geron Corporation. From 2006 until 2011, Mr. Cooper served as Chief Financial Officer of Orexigen Therapeutics, Inc. From 1999 to 2006, Mr. Cooper held positions of increasing responsibility including Director, Health Care Investment Banking, at Deutsche Bank Securities. From August 1992 to January 1995, he worked as an accountant at Deloitte & Touche, where he earned his C.P.A. Mr. Cooper holds a B.A. in Economics from the University of California at Berkeley, and an M.B.A. from the Stanford Graduate School of Business.